MedTrace Logo

Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal

NCT01553552 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2012-03-14

No results posted yet for this study

Summary

SchistoVAN aims to study the role of schistosomiasis infection in the modulation of the immune response of children to childhood vaccine antigens, as well as the impact of this infection on their nutritional status and their haemoglobinaemia.

Conditions

  • Schistosomiasis
  • Anemia
  • Underweight
  • Stunting
  • Intestinal Parasites

Sponsors & Collaborators

  • Institut Pasteur de Lille

    collaborator OTHER

  • University of Lille Nord de France

    collaborator OTHER

  • Région Nord-Pas de Calais, France

    collaborator OTHER

  • Centre d'Infection et d'Immunité de Lille

    collaborator OTHER

  • Centre National de la Recherche Scientifique, France

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Biomedical Research Center EPLS

    lead OTHER

Principal Investigators

  • Emmanuel Hermann, PhD A.Pr. · Biomedical Research Center EPLS

  • Lobna Gaayeb, VetMed · Biomedical Research Center EPLS

  • Modou Seck, MD · Biomedical Research Center EPLS

Eligibility

Min Age
6 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Senegal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01553552 on ClinicalTrials.gov